Cargando…
Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum
INTRODUCTION: The aging process involves numerous biological mechanisms that have been characterized and proposed as the “hallmarks of aging.” Targeting the processes and pathways related to these hallmarks of aging that cause and promote skin aging could provide anti-aging benefits. A novel topical...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823186/ https://www.ncbi.nlm.nih.gov/pubmed/36374431 http://dx.doi.org/10.1007/s13555-022-00839-2 |
_version_ | 1784866100024967168 |
---|---|
author | Naughton, Gail K. Jiang, Lily I. Makino, Elizabeth T. Chung, Robin Nguyen, Audrey Cheng, Tsing Kadoya, Kuniko Mehta, Rahul C. |
author_facet | Naughton, Gail K. Jiang, Lily I. Makino, Elizabeth T. Chung, Robin Nguyen, Audrey Cheng, Tsing Kadoya, Kuniko Mehta, Rahul C. |
author_sort | Naughton, Gail K. |
collection | PubMed |
description | INTRODUCTION: The aging process involves numerous biological mechanisms that have been characterized and proposed as the “hallmarks of aging.” Targeting the processes and pathways related to these hallmarks of aging that cause and promote skin aging could provide anti-aging benefits. A novel topical growth factor-based skin care serum (A+) was developed using human fibroblast conditioned media. This study aimed to assess the effects of A+ on four hallmarks of aging and its clinical efficacy in skin rejuvenation in subjects with moderate to severe overall facial photodamage. METHODS: Preclinical studies included immunohistochemistry in human ex vivo skin, and gene expression analysis in human 3D skin models. A 24-week, vehicle placebo-controlled study, including FaceQ patient-reported outcomes and skin biopsy analysis, was performed to assess clinical efficacy and tolerability. RESULTS: Treatment with A+ resulted in reduced expression of cell senescence biomarker H2A.J and upregulation of genes associated with proteasome, autophagy, stemness, and intercellular communication. Clinical assessments showed A+ provided significantly greater reductions in sagging, coarse lines/wrinkles, fine lines/wrinkles, overall photodamage, and overall hyperpigmentation compared with placebo. Subjects felt they appeared younger-looking, reporting a median decrease in self-perceived age of 6 years after 12 weeks of use. Decreased levels of H2A.J and increased expression of key dermal extracellular matrix and epidermal barrier components, including collagen and elastin, were observed in skin biopsy samples. CONCLUSION: The present study shows for the first time the potential effects of a topical growth factor-based cosmeceutical on cellular processes related to four hallmarks of aging (cellular senescence, loss of proteostasis, stem cell exhaustion, and altered intercellular communication) to help delay the aging process and restore aged skin. A+ targets the biological mechanisms underlying the aging process itself and stimulates skin regeneration, resulting in rapid and significant clinical improvements. |
format | Online Article Text |
id | pubmed-9823186 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-98231862023-01-08 Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum Naughton, Gail K. Jiang, Lily I. Makino, Elizabeth T. Chung, Robin Nguyen, Audrey Cheng, Tsing Kadoya, Kuniko Mehta, Rahul C. Dermatol Ther (Heidelb) Original Research INTRODUCTION: The aging process involves numerous biological mechanisms that have been characterized and proposed as the “hallmarks of aging.” Targeting the processes and pathways related to these hallmarks of aging that cause and promote skin aging could provide anti-aging benefits. A novel topical growth factor-based skin care serum (A+) was developed using human fibroblast conditioned media. This study aimed to assess the effects of A+ on four hallmarks of aging and its clinical efficacy in skin rejuvenation in subjects with moderate to severe overall facial photodamage. METHODS: Preclinical studies included immunohistochemistry in human ex vivo skin, and gene expression analysis in human 3D skin models. A 24-week, vehicle placebo-controlled study, including FaceQ patient-reported outcomes and skin biopsy analysis, was performed to assess clinical efficacy and tolerability. RESULTS: Treatment with A+ resulted in reduced expression of cell senescence biomarker H2A.J and upregulation of genes associated with proteasome, autophagy, stemness, and intercellular communication. Clinical assessments showed A+ provided significantly greater reductions in sagging, coarse lines/wrinkles, fine lines/wrinkles, overall photodamage, and overall hyperpigmentation compared with placebo. Subjects felt they appeared younger-looking, reporting a median decrease in self-perceived age of 6 years after 12 weeks of use. Decreased levels of H2A.J and increased expression of key dermal extracellular matrix and epidermal barrier components, including collagen and elastin, were observed in skin biopsy samples. CONCLUSION: The present study shows for the first time the potential effects of a topical growth factor-based cosmeceutical on cellular processes related to four hallmarks of aging (cellular senescence, loss of proteostasis, stem cell exhaustion, and altered intercellular communication) to help delay the aging process and restore aged skin. A+ targets the biological mechanisms underlying the aging process itself and stimulates skin regeneration, resulting in rapid and significant clinical improvements. Springer Healthcare 2022-11-14 /pmc/articles/PMC9823186/ /pubmed/36374431 http://dx.doi.org/10.1007/s13555-022-00839-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Naughton, Gail K. Jiang, Lily I. Makino, Elizabeth T. Chung, Robin Nguyen, Audrey Cheng, Tsing Kadoya, Kuniko Mehta, Rahul C. Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum |
title | Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum |
title_full | Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum |
title_fullStr | Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum |
title_full_unstemmed | Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum |
title_short | Targeting Multiple Hallmarks of Skin Aging: Preclinical and Clinical Efficacy of a Novel Growth Factor-Based Skin Care Serum |
title_sort | targeting multiple hallmarks of skin aging: preclinical and clinical efficacy of a novel growth factor-based skin care serum |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823186/ https://www.ncbi.nlm.nih.gov/pubmed/36374431 http://dx.doi.org/10.1007/s13555-022-00839-2 |
work_keys_str_mv | AT naughtongailk targetingmultiplehallmarksofskinagingpreclinicalandclinicalefficacyofanovelgrowthfactorbasedskincareserum AT jianglilyi targetingmultiplehallmarksofskinagingpreclinicalandclinicalefficacyofanovelgrowthfactorbasedskincareserum AT makinoelizabetht targetingmultiplehallmarksofskinagingpreclinicalandclinicalefficacyofanovelgrowthfactorbasedskincareserum AT chungrobin targetingmultiplehallmarksofskinagingpreclinicalandclinicalefficacyofanovelgrowthfactorbasedskincareserum AT nguyenaudrey targetingmultiplehallmarksofskinagingpreclinicalandclinicalefficacyofanovelgrowthfactorbasedskincareserum AT chengtsing targetingmultiplehallmarksofskinagingpreclinicalandclinicalefficacyofanovelgrowthfactorbasedskincareserum AT kadoyakuniko targetingmultiplehallmarksofskinagingpreclinicalandclinicalefficacyofanovelgrowthfactorbasedskincareserum AT mehtarahulc targetingmultiplehallmarksofskinagingpreclinicalandclinicalefficacyofanovelgrowthfactorbasedskincareserum |